JPMorgan Reinstated Imprivata (IMPR) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Barclays Starts Imprivata (IMPR) at Overweight
August 17, 2015 7:49 AM EDTBarclays initiated coverage on Imprivata (NYSE: IMPR) with an Overweight rating and a price target of $28.00.
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $18.72 yesterday.
... MoreStifel Starts Imprivata (IMPR) at Buy
August 17, 2015 7:48 AM EDTStifel initiated coverage on Imprivata (NYSE: IMPR) with a Buy rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.
Shares of Imprivata closed at $18.72 yesterday.
... More